Simultaneous quantitative determination of calcium leucovorin and parabens in lyophilized ampoules by derivative spectroscopyBERTINI, J; COCCHINI, A; LAMONACA, F et al.Il Farmaco (Pavia). 1992, Vol 47, Num 7-8, pp 1105-1114, issn 0014-827XArticle

Biosimilaires actuellement disponibles en hémato-oncologie Partie 1: ASEs (agents stimulant l'érythropoïèse) : Les Biosimilaires = Presently available biosimilars in hematology-oncology ― Part I: ESAs : BiosimilarsKAMIONER, D; DICATO, M.Oncologie (Paris). 2011, Vol 13, Num 5, pp 209-212, issn 1292-3818, 4 p.Article

Emerging therapies in oncology care: focus on epoetin alfaSeminars in oncology. 1998, Vol 25, Num 3, issn 0093-7754, 83 p., SUP7Conference Proceedings

Suplemento antianemico liquido a partir de sangre entera = Antianemia liquid supplement from bovine whole bloodMARTIN, M; VALLADARES, C; GUERRA, M. A et al.Alimentaria. 1997, Num 288, pp 99-101, issn 0300-5755Article

Chemiron : a new hematinic preparation. How effective during pregnancy ?OGUNBODE, O; OTUBU, J. A. M; BRIGGS, N. D et al.Current therapeutic research. 1992, Vol 51, Num 1, pp 163-173, issn 0011-393XArticle

Pharmacologic and cytokine treatment of commonly encountered anemiasFOOTE, Maryann; COLOWICK, Alan; GOODKIN, David A et al.Cytokines, cellular & molecular therapy. 2002, Vol 7, Num 2, pp 49-59, issn 1368-4736, 11 p.Article

Erythropoietin response to blood loss in hemodialysis patients is blunted but preservedROSS, R. P; MCCREA, J. B; BESARAB, A et al.ASAIO journal (1992). 1994, Vol 40, Num 3, pp M880-M885, issn 1058-2916Article

Erythropoietin for the prevention of anaemia in neoplastic patients treated with cisplatinGAMUCCI, T; THOREL, M. F; FRASCA, A. M et al.Applications of recombinant human erythropoietin in cancer patients. European journal of cancer. Part A. 1993, Vol 29, pp S13-S14, SUP2Book Chapter

Population pharmacokinetics of darbepoetin alfa in healthy subjectsAGORAM, Balaji; SUTJANDRA, Liviawati; SULLIVAN, John T et al.British journal of clinical pharmacology. 2007, Vol 63, Num 1, pp 41-52, issn 0306-5251, 12 p.Article

Is there a place for epoetin alfa in managing anemia during critical illness?GIVENS, Marlea; LAPOINTE, Marc.Clinical therapeutics. 2004, Vol 26, Num 6, pp 819-829, issn 0149-2918, 11 p.Article

Erythroblastopénies sous époétine (suite) = Red cell aplasie under epoetin alfa (continuation)La Revue Prescrire. 2003, Vol 23, Num 236, issn 0247-7750, p. 111Article

Guidelines for using darbepoetin alfa in patients with chemotherapy-induced anemiaBLOOMFIELD, Michael; JARESKO, George; ZAREK, John et al.Pharmacotherapy. 2003, Vol 23, pp 110S-118S, issn 0277-0008, 2Article

Perioperativer Einsatz von rhEPO bei Angehörigen der Glaubensgemeinschaft Zeugen Jehovas = The perioperative use of recombinant erythropoietin (rhEPO) in Jehovah's witnessesSOUKUP, J; MENZEL, M; ROTH, S et al.Der Anaesthesist (Berlin. Print). 1996, Vol 45, Num 8, pp 745-749, issn 0003-2417Article

Micellar-enhanced synchronous-derivative fluorescence determination of derivatized folic acid in pharmaceutical preparationsCRUCES BLANCO, C; SEGURA CARRETERO, A; FERNANDEZ GUTIERREZ, A et al.Journal of pharmaceutical and biomedical analysis. 1995, Vol 13, Num 8, pp 1019-1025, issn 0731-7085Article

Application of ternary complexes in pharmaceutical analysis. III: Spectrophotometric microdetermination of iron(II) in anti-anaemic formulationsISSOPOULOS, P. B; ECONOMOU, P. T.Fresenius' journal of analytical chemistry. 1993, Vol 345, Num 8-9, pp 595-599, issn 0937-0633Article

Controversies in determination of epoetin (recombinant human erythropoietin) dosagesABRAHAM, P. A; SAINT PETER, W. L; REDIC-KILL, K. A et al.Clinical pharmacokinetics. 1992, Vol 22, Num 6, pp 409-415, issn 0312-5963Article

The importance of reductive mechanisms for intestinal uptake of iron from ferric maltol and ferric nitrilotriacetic acid (NTA)BARRAND, M. A; HIDER, R. C; CALLINGHAM, B. A et al.Journal of pharmacy and pharmacology. 1990, Vol 42, Num 4, pp 279-282, issn 0022-3573, 4 p.Article

Développement clinique du premier ASE enregistré selon la voie de développement européenne des biosimilairesCANAUD, B.Néphrologie & thérapeutique. 2009, Vol 5, pp 16-20, issn 1769-7255, 5 p., HS1Article

Alfa-epoietin and anaemia in gynaecological cancerDI COCCO, Barbara; SALESI, Nello; FABI, Alessandra et al.Anticancer research. 2004, Vol 24, Num 2C, pp 1287-1292, issn 0250-7005, 6 p.Article

Investigations into the role of methylcobalamin and glutathione for the methylation of antimony using isotopically enriched antimony(V)WEHMEIER, Silvia; RAAB, Andrea; FELDMANN, Jörg et al.Applied organometallic chemistry. 2004, Vol 18, Num 12, pp 631-639, issn 0268-2605, 9 p.Conference Paper

Erythropoetin: Physiologische Bedeutung und Konsequenzen für den therapeutischen Einsatz : Trends und neue Richtlinien in der Transfusionsmedizin = Erythropoetin : Physiological importance and consequences in therapeutic use : Trends and new guidelines in transfusion medicineECKARDT, K.-U.AINS. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 1998, Vol 33, Num 10, pp 670-673, issn 0939-2661Article

Magnetic properties of iron dextranKILCOYNE, S. H; GORISEK, A.Journal of magnetism and magnetic materials. 1998, Vol 177-81, pp 1457-1458, issn 0304-8853, 2Conference Paper

Transfusions en chirurgie : peuvent-elles encore être réduites par l'érythropoïétine humaine recombinante ? = Transfusions in surgery : can they further be decreased with recombinant humain erythropoietin ?JANVIER, G; ROTH, C; BENILLAN, N et al.Annales françaises d'anesthésie et de réanimation. 1996, Vol 15, Num 8, pp 1219-1229, issn 0750-7658Article

Erythropoietin treatment of chronic anaemia of cancerLUDWIG, H; LEITGEB, C; FRITZ, E et al.Applications of recombinant human erythropoietin in cancer patients. European journal of cancer. Part A. 1993, Vol 29, pp S8-S12, SUP2Book Chapter

Criteria for use of epoetinClinical pharmacy. 1991, Vol 10, Num 2, pp 143-146, issn 0278-2677, 4 p.Article